• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Life Sci Alliance . Transmembrane protease serine 2 ( TMPRSS2) rs75603675, comorbidity, and sex are the primary predictors of COVID-19 severity

tetano

Editor, Senior Moderator
Life Sci Alliance


. 2022 May 30;5(10):e202201396.
doi: 10.26508/lsa.202201396. Print 2022 Oct.
Transmembrane protease serine 2 ( TMPRSS2) rs75603675, comorbidity, and sex are the primary predictors of COVID-19 severity


Gonzalo Villapalos-García[SUP] 1 [/SUP], Pablo Zubiaur[SUP] 2 3 [/SUP], Rebeca Rivas-Durán[SUP] 4 [/SUP], Pilar Campos-Norte[SUP] 4 [/SUP], Cristina Arévalo-Román[SUP] 4 [/SUP], Marta Fernández-Rico[SUP] 4 [/SUP], Lucio García-Fraile Fraile[SUP] 4 [/SUP], Paula Fernández-Campos[SUP] 1 [/SUP], Paula Soria-Chacartegui[SUP] 1 [/SUP], Sara Fernández de Córdoba-Oñate[SUP] 5 [/SUP], Pablo Delgado-Wicke[SUP] 5 [/SUP], Elena Fernández-Ruiz[SUP] 5 [/SUP], Isidoro González-Álvaro[SUP] 6 [/SUP], Jesús Sanz[SUP] 4 [/SUP], Francisco Abad-Santos[SUP] 7 3 [/SUP], Ignacio de Los Santos[SUP] 8 [/SUP]



Affiliations

Abstract

By the end of December 2021, coronavirus disease 2019 (COVID-19) produced more than 271 million cases and 5.3 million deaths. Although vaccination is an effective strategy for pandemic control, it is not yet equally available in all countries. Therefore, identification of prognostic biomarkers remains crucial to manage COVID-19 patients. The aim of this study was to evaluate predictors of COVID-19 severity previously proposed. Clinical and demographic characteristics and 120 single-nucleotide polymorphisms were analyzed from 817 patients with COVID-19, who attended the emergency department of the Hospital Universitario de La Princesa during March and April 2020. The main outcome was a modified version of the 7-point World Health Organization (WHO) COVID-19 severity scale (WHOCS); both in the moment of the first hospital examination (WHOCS-1) and of the severest WHOCS score (WHOCS-2). The TMPRSS2 rs75603675 genotype (OR = 0.586), dyslipidemia (OR = 2.289), sex (OR = 0.586), and the Charlson Comorbidity Index (OR = 1.126) were identified as the main predictors of disease severity. Consequently, these variables might influence COVID-19 severity and could be used as predictors of disease development.
 
Back
Top Bottom